Nursing Home Settles Allegations of Submitting False Claims for $2.7M

|

A nursing home management company has agreed to pay $2.7 million to the federal government to resolve a whistleblower lawsuit that alleged the company tried to defraud Medicare by submitting false claims. 

The settlement was reached between Grace Healthcare and the U.S. Department of Justice (DOJ) after the nursing home management company was accused of giving therapy to residents who did not need it in order to boost its Medicare reimbursements. The DOJ announced the settlement in a press release issued on March 8.

According to the DOJ, Grace Healthcare provided unnecessary therapy from 2007 to 2011, including occupational therapy, physical therapy, and speech therapy, to patients in order to boost Medicare revenue at 10 different facilities run by the Tennessee-based company.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

In addition to the $2.7 million payment, the company has entered into a Corporate Integrity Agreement. The agreement is between the company and the Department of Health and Human Services Office of Inspector General (DHHS-OIG).

“In today’s economic climate, it is more important than ever for the United States to make sure that Medicare and Medicaid funds are spent appropriately,” said Stuart F. Delery, Principal Deputy Assistant Attorney General for the Civil Division of the DOJ in the press release. “The Department of Justice will not tolerate those who abuse government health care programs by providing services based on their own financial considerations, rather than the needs of their patients.”

The case was brought to the government’s attention by a former Grace employee, who filed a whistleblower lawsuit. The employee will be paid about $405,000 out of the settlement as a reward for bringing the case to the government’s attention.

Under the qui tam provisions of the act, whistleblowers who expose the fraud by revealing information not publicly accessible are entitled to a portion of the money recovered. Whistleblowers must be the first to bring the case to the government’s attention and not publicize the lawsuit until the DOJ decides whether to join the prosecution of the case.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A New York woman has filed a lawsuit alleging that her long term use of Depo Provera caused her to develop a meningioma brain tumor, which she contends resulted from the manufacturer’s negligence and failure to adequately warn about the risks.
A group of plaintiffs has petitioned the U.S. Judicial Panel on Multidistrict Litigation to centralize all Dupixent lymphoma lawsuits before a single judge for coordinated pretrial proceedings, a move that could ultimately lead to bellwether trials and a global resolution of the claims.
Bayer and Monsanto say they have reached a $7.25 billion Roundup cancer lawsuit settlement resolving more than 100,000 claims as well as any future litigation that may be filed.